Chronic obstructive pulmonary disease is associated with low levels of vitamin D

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Persson, Louise Jeanette Pauline ^a   Aanerud, Marianne ^a   Hiemstra, Pieter Sicco ^c   Hardie, Jon Andrew ^a,b   Bakke, Per Sigvald ^b   Eagan, Tomas Mikal Lind ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; STEROID;

ADULT; AGE; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DYSPNEA; FEMALE; HUMAN; HYPOXEMIA; LEUKOCYTE COUNT; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEASONAL VARIATION; SMOKING HABIT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; COHORT STUDIES; DEPRESSION; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; NORWAY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; RISK; RISK FACTORS; SEASONS; VITAMIN D;

EID: 84862663710     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038934     Document Type: Article

References (34)

1. Holick MF, (2007) Vitamin D deficiency. N Engl J Med 357: 266-281.
2. Lips P, (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22: 477-501.
3. van der Wielen RP, Lowik MR, van den Berg H, de Groot LC, Haller J, et al. (1995) Serum vitamin D concentrations among elderly people in Europe. Lancet 346: 207-210.
4. Black PN, Scragg R, (2005) Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest 128: 3792-3798.
5. Ginde AA, Mansbach JM, Camargo CAJ, (2009) Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 169: 384-390.
6. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, et al. (2006) Epidemic influenza and vitamin D. Epidemiol Infect 134: 1129-1140.
7. Brehm JM, Celedon JC, Soto-Quiros ME, Avila L, Hunninghake GM, et al. (2009) Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med 179: 765-771.
8. Devereux G, Litonjua AA, Turner SW, Craig LC, McNeill G, et al. (2007) Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr 85: 853-859.
9. Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, et al. (2010) Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 65: 215-220.
10. Forli L, Halse J, Haug E, Bjortuft O, Vatn M, et al. (2004) Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease. J Intern Med 256: 56-62.
11. Kunisaki KM, Niewoehner DE, Connett JE, (2011) Vitamin D Levels and Risk of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: a Prospective Cohort Study. Am J Respir Crit Care Med.
12. Eagan TM, Ueland T, Wagner PD, Hardie JA, Mollnes TE, et al. (2010) Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J 35: 540-548.
13. Saure EW, Eagan TM, Jensen RL, Voll-Aanerud M, Aukrust P, et al. (2011) Explained variance for blood gases in a population with COPD. Clin Respir J.
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR, (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383.
15. Radloff LS, (1977) The CES-D Scale: A Self-Report Depression Scale for Research in the General Population. Applied psychological measurement 1: 385-401.
16. Grimnes G, Almaas B, Eggen AE, Emaus N, Figenschau Y, et al. (2010) Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed. Eur J Endocrinol 163: 339-348.
17. Brot C, Jorgensen NR, Sorensen OH, (1999) The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr 53: 920-926.
18. Sutherland ER, Goleva E, Jackson LP, Stevens AD, Leung DY, (2010) Vitamin D levels, lung function, and steroid response in adult asthma. Am J Respir Crit Care Med 181: 699-704.
19. Cosio BG, Agusti A, (2010) Update in chronic obstructive pulmonary disease 2009. Am J Respir Crit Care Med 181: 655-660.
20. Penna G, Adorini L, (2000) 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164: 2405-2411.
21. Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, et al. (1985) 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 134: 3032-3035.
22. Adams JS, Hewison M, (2008) Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 4: 80-90.
23. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, et al. (2004) Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173: 2909-2912.
24. Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, et al. (2008) Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 181: 7090-7099.
25. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA, (2002) Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57: 847-852.
26. Dobak J, Grzybowski J, Liu FT, Landon B, Dobke M, (1994) 1,25-Dihydroxyvitamin D3 increases collagen production in dermal fibroblasts. J Dermatol Sci 8: 18-24.
27. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, et al. (2002) Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 95: 787-796.
28. Schlaich C, Minne HW, Bruckner T, Wagner G, Gebest HJ, et al. (1998) Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int 8: 261-267.
29. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF, (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72: 690-693.
30. Stewart R, Hirani V, (2010) Relationship between vitamin D levels and depressive symptoms in older residents from a national survey population. Psychosom Med 72: 608-612.
31. Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K, (2008) Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 264: 599-609.
32. Milaneschi Y, Shardell M, Corsi AM, Vazzana R, Bandinelli S, et al. (2010) Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J Clin Endocrinol Metab 95: 3225-3233.
33. Lehouck A, Mathieu C, Carremans C, Baeke F, Verhaegen J, et al. (2012) High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease. A randomized trial. Ann Intern Med 156: 105-114.
34. Williams AF, (2007) Update on vitamin D. Position statement by the Scientific Advisory Committee on Nutrition. Available: http://www.sacn.gov.uk/pdfs/sacn_position_vitamin_d_2007_05_07.pdf Accessed 2012 Feb 12.